4 found
Order:
  1.  57
    Human germ-line therapy: The case for its development and use.Burke K. Zimmerman - 1991 - Journal of Medicine and Philosophy 16 (6):593-612.
    The rationale for pursuing the development and use of Germ-Line selection and modification techniques is examined in this essay. The argument is put forth that it is the moral obligation of the medical profession to make available to the public any technology that can cure or prevent pathology leading to death and disability, in both the present and future generations. Society should pursue the development of strategies for preventing or correcting, at the Germ-Line level, genetic features that will lead to, (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  2. Germ-line Gene therapy and the clinical ethos of medical Genetics.Gregory Fowler, Eric T. Juengst & Burke K. Zimmerman - 1989 - Theoretical Medicine and Bioethics 10 (2).
    Although the ability to perform gene therapy in human germ-line cells is still hypothetical, the rate of progress in molecular and cell biology suggests that it will only be a matter of time before reliable clinical techniques will be within reach. Three sets of arguments are commonly advanced against developing those techniques, respectively pointing to the clinical risks, social dangers and better alternatives. In this paper we analyze those arguments from the perspective of the client-centered ethos that traditionally governs practice (...)
     
    Export citation  
     
    Bookmark   3 citations  
  3.  4
    Beyond Recombinant DNA—Two Views of the Future.Burke K. Zimmerman - 1978 - In John Richards (ed.), Recombinant DNA: science, ethics, and politics. New York: Academic Press. pp. 273.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  4. Recombinant dna: Science. Ethics. And politics.Burke K. Zimmerman - 1978 - In John Richards (ed.), Recombinant DNA: science, ethics, and politics. New York: Academic Press. pp. 273.